HIKMA PHARMACEUTICALS PLC financial statements, including revenue, expenses, profit, and loss
The total revenue of HIK for the last semiannual is 1.57 B USD, and it's 9.22% higher compared to the previous semiannual. The net income of H1 24 is 226.00 M USD.